We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Oxford University’s Rapid COVID-19 Test Detects SARS-CoV-2 Within 30-45 Minutes

By LabMedica International staff writers
Posted on 17 Jul 2020
Scientists have developed a rapid test which detects the presence of the SARS-CoV-2 virus and could be adapted for use in settings ranging from community care, schools, airports or home self-testing.

The test for the detection of COVID-19 has been developed by the University of Oxford’s Department of Engineering Science and Oxford Suzhou Centre for Advanced Research (OSCAR Oxford, UK). More...
The Oxford-OSCAR team has designed primers with high specificity to confirm presence of the virus in infected people, adapted from an established technology known as RT-LAMP (reverse transcription-loop mediated isothermal amplification). It is a simplified one-step version of a viral RNA test and can be used in the field without specialist equipment or training. The simple colorimetric result is read by eye or fluorescent display, meaning there is no need for additional tools to analyze results. A Bluetooth-linked fluorescent detection instrument can link the test result into a laboratory information system, so that test results can be tracked.

The test produces results within 30-45 minutes and detects SARS-CoV-19 with great sensitivity and specificity using throat/nasal swabs directly to identify individuals carrying the virus. Clinical trials have generated comparable results with laboratory tests, demonstrating reliability, and the results will be published shortly. The test will soon be certified with CE-mark. It will be available in quantity with the commercial product name Oxsed RaViD Direct at a cost of no more than GBP 20 per test, which is considerably cheaper than most of the products currently on market.

“By designing the specific primers and controlling the biochemical reaction, we are able to eliminate the non-specific reactions that cause false positives and make our RT-LAMP test robust. And the Oxford test can be transported and stored at ambient temperature without need for cold chain, which makes shipping and distribution much easier,” said Professor Wei Huang who designed the primers to target the viral RNA.

“Our test is ideal for use in community or field settings by lay persons and allows immediate decisions to be made. Immediate applications are: returning to work/education (i.e. schools, universities, companies) and making quarantine decision (e.g. care homes, hospitals, temporary migrants, tourists). Use of such a test could be crucial to economic recovery globally,” said Prof Zhanfeng Cui, the Director of OSCAR.

Related Links:
University of Oxford


Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Collection and Transport System
PurSafe Plus®
Gold Member
Automatic Hematology Analyzer
DH-800 Series
New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Elecsys Dengue Ag assay is intended for the in vitro qualitative detection of dengue virus NS1 antigen in human serum and plasma (Photo courtesy of Roche)

Automated Test Distinguishes Dengue from Acute Fever-Causing Illnesses In 18 Minutes

Dengue fever remains the most common mosquito-borne viral infection worldwide, posing a major public health challenge as global cases continue to surge. In 2024 alone, more than 14.6 million infections... Read more

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.